» Articles » PMID: 20921544

Age at Cancer Diagnosis Among Persons with AIDS in the United States

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2010 Oct 6
PMID 20921544
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies have reported young ages at cancer diagnosis in HIV-infected persons and have suggested that HIV accelerates carcinogenesis. However, these comparisons did not account for differences in population age structures.

Objective: To compare ages at diagnosis for non-AIDS-defining types of cancer that occur in both the AIDS and general populations, after adjustment for differences in age and other demographic characteristics between these populations.

Design: Registry linkage study.

Setting: 15 HIV/AIDS and cancer registry databases in the United States.

Participants: 212 055 persons with AIDS enrolled in the U.S. HIV/AIDS Cancer Match Study from 1996 to 2007.

Measurements: Comparison of age-at-diagnosis distributions for various types of cancer in both the AIDS and general populations, after adjustment for age and other demographic characteristics.

Results: The proportion of person-time contributed by older persons (age ≥65 years) was far smaller in the AIDS population (1.5%) than in the general population (12.5%). Reflecting this difference, the ages at diagnosis for most types of cancer were approximately 20 years younger among persons with AIDS. However, after adjustment for differences in the populations at risk, the median ages at diagnosis in the AIDS and general populations did not differ for most types of cancer (for example, colon, prostate, or breast cancer; all P > 0.100). In contrast, ages at diagnosis of lung (median, 50 vs. 54 years) and anal cancer (median, 42 vs. 45 years) were significantly younger in persons with AIDS than expected in the general population (P < 0.001), and the age at diagnosis of Hodgkin lymphoma was significantly older (median, 42 vs. 40 years; P < 0.001).

Limitations: Information on other cancer risk factors, including cigarette smoking, was not available. Analysis was restricted to non-Hispanic white and black persons who had AIDS, which could limit the generalizability of the findings to other racial and ethnic groups or to persons with HIV but not AIDS.

Conclusion: For most types of cancer, the age at diagnosis is similar in the AIDS and general populations, after adjustment for the ages of the populations at risk. Modest age differences remained for a few types of cancer, which may indicate either acceleration of carcinogenesis by HIV or earlier exposure to cancer risk factors.

Primary Funding Source: National Cancer Institute.

Citing Articles

The impact of tobacco smoking and smoking cessation on lung cancer and stroke incidence among people with HIV on antiretroviral therapy in South Africa: a simulation modeling study.

DCouto H, Thielking A, Sewpaul R, Levy D, Rigotti N, Chrysanthopoulou S BMJ Glob Health. 2024; 9(12).

PMID: 39675836 PMC: 11647297. DOI: 10.1136/bmjgh-2024-017049.


Adaptation of a Tailored Lung Cancer Screening Decision Aid for People With HIV.

Brown M, Snidarich M, Budak J, Murphy N, Giustini N, Romine P CHEST Pulm. 2024; 2(3).

PMID: 39391570 PMC: 11465906. DOI: 10.1016/j.chpulm.2024.100044.


Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.

Pirsl F, Calkins K, Rudolph J, Wentz E, Xu X, Lau B AIDS Care. 2024; 36(11):1657-1667.

PMID: 39079500 PMC: 11511642. DOI: 10.1080/09540121.2024.2383875.


Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort.

Nakanjako D, Nabatanzi R, Ssinabulya I, Bayigga L, Kiragga A, Banturaki G Heliyon. 2024; 10(11):e31910.

PMID: 38882354 PMC: 11177148. DOI: 10.1016/j.heliyon.2024.e31910.


Recent and projected incidence trends and risk of anal cancer among people with HIV in North America.

Deshmukh A, Lin Y, Damgacioglu H, Shiels M, Coburn S, Lang R J Natl Cancer Inst. 2024; 116(9):1450-1458.

PMID: 38713084 PMC: 11378305. DOI: 10.1093/jnci/djae096.


References
1.
Shiels M, Cole S, Kirk G, Poole C . A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009; 52(5):611-22. PMC: 2790038. DOI: 10.1097/QAI.0b013e3181b327ca. View

2.
Alshafie M, Donaldson B, Oluwole S . Human immunodeficiency virus and lung cancer. Br J Surg. 1997; 84(8):1068-71. View

3.
Long J, Engels E, Moore R, Gebo K . Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008; 22(4):489-96. PMC: 2553213. DOI: 10.1097/QAD.0b013e3282f47082. View

4.
Brock M, Hooker C, Engels E, Moore R, Gillison M, Alberg A . Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr. 2006; 43(1):47-55. DOI: 10.1097/01.qai.0000232260.95288.93. View

5.
Tobias C, Cunningham W, Cunningham C, Pounds M . Making the connection: the importance of engagement and retention in HIV medical care. AIDS Patient Care STDS. 2007; 21 Suppl 1:S3-8. DOI: 10.1089/apc.2007.9992. View